This week's psychedelic highlights: Psilocybin shows promise with 79% remission rates in depression treatment. Early trials explore MEAI for obesity. Ketamine's single dose proves effective for anxiety, psychedelics birth environmentalists & more.
https://t.co/fYY1Uf6jSE
Have you heard of kanna? 🌿 Kanna isn’t psychedelic, but it’s legal and touted as a natural empathogen. DB co-founder Shelby Hartman explores this potent plant medicine in our latest video on YouTube. 👇
https://t.co/FepM3Euimg
🍄Scientific studies indicate #psilocybin mushrooms’ potential in alleviating #anxiety, #depression & #PTSD. Ready to optimize your mental well-being?
#CyberMonday get 25% off Third Wave’s Mushroom Grow Kit; use code “cybermonday25" at checkout: https://t.co/qTGiLMXbI4
The potential of psychedelics to heal our racial traumas
Clinical psychologist Monnica Williams is on a mission to bring psychedelics to therapists’ offices to help people heal from their racial traumas. To do this, she’s jumping over some big hurdles.
https://t.co/Hk5cpvMdEF